Target Price | $217.22 |
Price | $201.64 |
Potential |
7.73%
register free of charge
|
Number of Estimates | 23 |
23 Analysts have issued a price target AbbVie 2026 .
The average AbbVie target price is $217.22.
This is
7.73%
register free of charge
$251.00
24.48%
register free of charge
$173.00
14.20%
register free of charge
|
|
A rating was issued by 29 analysts: 19 Analysts recommend AbbVie to buy, 9 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the AbbVie stock has an average upside potential 2026 of
7.73%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 56.33 | 59.52 |
3.71% | 5.66% | |
EBITDA Margin | 44.40% | 48.57% |
9.95% | 9.40% | |
Net Margin | 7.49% | 20.66% |
15.28% | 175.86% |
20 Analysts have issued a sales forecast AbbVie 2025 . The average AbbVie sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an AbbVie EBITDA forecast 2025. The average AbbVie EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 AbbVie Analysts have issued a net profit forecast 2025. The average AbbVie net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 2.39 | 6.97 |
12.13% | 191.63% | |
P/E | 28.94 | |
EV/Sales | 7.04 |
7 Analysts have issued a AbbVie forecast for earnings per share. The average AbbVie EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Wells Fargo |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
B of A Securities |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
Raymond James |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
BMO Capital |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
Analyst Rating | Date |
---|---|
Locked
Wells Fargo:
Locked
➜
Locked
|
Mar 05 2025 |
Locked
B of A Securities:
Locked
➜
Locked
|
Mar 04 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Feb 03 2025 |
Locked
Raymond James:
Locked
➜
Locked
|
Feb 03 2025 |
Locked
BMO Capital:
Locked
➜
Locked
|
Feb 03 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Feb 03 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Feb 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.